HARLEYSVILLE, Pennsylvania, March 23, 2011 /PRNewswire/ --
Colorcon, Inc., a wholly owned subsidiary of BPSI Holdings Inc., today announced specific details on its world-wide patent positions for enteric coating compositions in response to misleading statements made in the international press, particularly in India. These communications have inaccurately summarized the status of certain patents and patent applications. Colorcon has more than 15 patents for enteric coatings granted globally for the Acryl-EZE(R), aqueous acrylic enteric, and Sureteric(R), aqueous enteric systems, including valid patents in India. These patents remain in full effect.
"Colorcon will vigorously enforce its patent positions. We are proud of our strong history of research and development and the resulting innovative products we provide our customers," stated Kamlesh Oza, General Manager for Film Coatings. "Colorcon endeavors to provide best-in-class products and services to the pharmaceutical industry globally. Our recent customer survey indicates that, above all, the industry values our product range, technical support, and product use guidelines/application data. Our intellectual property estate enables us to continue investing in the development of advanced products and continually provide the industry with next generation formulated systems with superior overall value."
Colorcon is a world leader in the development, supply and support of formulated products for the pharmaceutical and nutritional industries. Its core businesses include film coatings, modified release technologies, functional excipients and tablet design services. Colorcon has 18 technical service laboratories globally and more than 1200 employees exclusively dedicated to its customer base.
The patents mentioned herein are owned by BPSI Holdings, Inc. Colorcon is the exclusive licensee.
SOURCE Colorcon, Inc.